PMC:7306567 / 16939-17075
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 191 | 52-64 | Chemical | denotes | voriconazole | MESH:D065819 |
| 194 | 127-135 | Disease | denotes | toxicity | MESH:D064420 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T109 | 71-72 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T116 | 26-30 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T117 | 52-64 | Chemical | denotes | voriconazole | http://purl.obolibrary.org/obo/CHEBI_10023 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T113 | 0-136 | Sentence | denotes | The impact of therapeutic drug monitoring (TDM) for voriconazole shows a clear relation between exposure and both efficacy and toxicity. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T135 | 26-30 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T136 | 52-64 | CHEBI:10023;CHEBI:10023 | denotes | voriconazole |
| T23351 | 26-30 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T23219 | 52-64 | CHEBI:10023;CHEBI:10023 | denotes | voriconazole |